529 related articles for article (PubMed ID: 33261131)
1. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.
Bessa C; Matos P; Jordan P; Gonçalves V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261131
[TBL] [Abstract][Full Text] [Related]
2. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
3. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
4. Splicing Regulators and Their Roles in Cancer Biology and Therapy.
da Silva MR; Moreira GA; Gonçalves da Silva RA; de Almeida Alves Barbosa É; Pais Siqueira R; Teixera RR; Almeida MR; Silva Júnior A; Fietto JL; Bressan GC
Biomed Res Int; 2015; 2015():150514. PubMed ID: 26273588
[TBL] [Abstract][Full Text] [Related]
5. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
7. Roles and mechanisms of alternative splicing in cancer - implications for care.
Bonnal SC; López-Oreja I; Valcárcel J
Nat Rev Clin Oncol; 2020 Aug; 17(8):457-474. PubMed ID: 32303702
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
[TBL] [Abstract][Full Text] [Related]
9. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
[TBL] [Abstract][Full Text] [Related]
11. Entropy measures quantify global splicing disorders in cancer.
Ritchie W; Granjeaud S; Puthier D; Gautheret D
PLoS Comput Biol; 2008 Mar; 4(3):e1000011. PubMed ID: 18369415
[TBL] [Abstract][Full Text] [Related]
12. Alternative spliced variants as biomarkers of colorectal cancer.
Yi Q; Tang L
Curr Drug Metab; 2011 Dec; 12(10):966-74. PubMed ID: 21787266
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Tsai YS; Dominguez D; Gomez SM; Wang Z
Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
[TBL] [Abstract][Full Text] [Related]
14. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
[TBL] [Abstract][Full Text] [Related]
15. Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.
Robinson TJ; Freedman JA; Al Abo M; Deveaux AE; LaCroix B; Patierno BM; George DJ; Patierno SR
Clin Cancer Res; 2019 May; 25(10):2963-2968. PubMed ID: 30755441
[TBL] [Abstract][Full Text] [Related]
16. Alternative spliced transcripts as cancer markers.
Caballero OL; de Souza SJ; Brentani RR; Simpson AJ
Dis Markers; 2001; 17(2):67-75. PubMed ID: 11673653
[TBL] [Abstract][Full Text] [Related]
17. Misregulation of pre-mRNA alternative splicing in cancer.
Zhang J; Manley JL
Cancer Discov; 2013 Nov; 3(11):1228-37. PubMed ID: 24145039
[TBL] [Abstract][Full Text] [Related]
18. Regulation of alternative splicing: more than just the ABCs.
House AE; Lynch KW
J Biol Chem; 2008 Jan; 283(3):1217-21. PubMed ID: 18024429
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing: an emerging topic in molecular and clinical oncology.
Pajares MJ; Ezponda T; Catena R; Calvo A; Pio R; Montuenga LM
Lancet Oncol; 2007 Apr; 8(4):349-57. PubMed ID: 17395108
[TBL] [Abstract][Full Text] [Related]
20. Splice variants as cancer biomarkers.
Brinkman BM
Clin Biochem; 2004 Jul; 37(7):584-94. PubMed ID: 15234240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
